GGrantIndex
Sort

46,585 grants matching heart failure

Treatment-Related Cardiotoxicity in Children with Relapsed Acute Myeloid Leukemia - Natural History, Occurrence and Implications

$676,727
Kelly Diringer Getz · University Of Pennsylvania · R01 · FY2024 · HL

Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft

$676,726
Jonathan Pieter Vande Geest · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL

Ultrasound-guided, Robotically Steerable Guidewire for Endovascular Interventions

$676,704
Jaydev P. Desai · Georgia Institute Of Technology · R01 · FY2022 · HL

Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring

$676,698
Kevin K McCully · Infrared Rx, Inc. · R42 · FY2019 · DK

CellTrap: A novel solid phase platform for analysis of stem/progenitor cells

$676,657
Nicanor I. Moldovan · Ohio State University · RC2 · FY2009 · AG

Mechanobiological mechanisms of pulmonary hypertension secondary to left heart failure

$676,638
Diana Marcela Tabima Martinez · University Of Wisconsin-Madison · R01 · FY2020 · HL

Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy

$676,392
Joseph C Wu · Stanford University · R01 · FY2025 · HL

Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin

$676,342
Mark Thomas Gladwin · University Of Maryland Baltimore · R01 · FY2025 · HL

Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking

$676,221
Diane Jeanette Treat-Jacobson · University Of Minnesota · R01 · FY2012 · HL

Comparing Quality and Cost of Care Across Nursing Environments

$676,211
Jeffrey H Silber · Children'S Hosp Of Philadelphia · R01 · FY2016 · NR

Plasticity of nTS output neurons in acute and chronic hypoxia

$676,205
Eileen M Hasser · University Of Missouri-Columbia · R01 · FY2014 · HL

EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE II

$676,195
University Of Pittsburgh At Pittsburgh · R01 · FY2000 · DK

Pathophysiology of Myocardial Disease

$676,148
Wendy S Post · Johns Hopkins University · T32 · FY2020 · HL

Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease

$676,107
Rozenn Lemaitre · University Of Washington · R01 · FY2020 · HL

PM2.5 Metals, Oxidative Potential, Exposure, and Risk Assessment (PM OPERA): A National Morbidity and Mortality Study

$676,077
John Volckens · Colorado State University · R56 · FY2024 · ES

Development of an Artificial Pump-Lung for Respiratory Failure

$676,053
Bartley Perry Griffith · University Of Maryland Baltimore · R01 · FY2011 · HL

Uncertainty aware virtual treatment planning for peripheral pulmonary artery stenosis

$676,028
Alison L Marsden · Stanford University · R01 · FY2024 · HL

Implementing Remote Patient Monitoring to Improve Hypertension Control in a Primary Care Network

$675,938
Ian Matthew Kronish · Columbia University Health Sciences · R01 · FY2024 · HL

Mechanical circulatory support: Measures of adjustment and quality of life

$675,936
Kathleen L Grady · Northwestern University At Chicago · R01 · FY2019 · HL

Patient-specific blood cell reactivity and flow dynamic profiles in transcatheter aortic valve replacement

$675,924
Monica T Hinds · Oregon Health & Science University · R01 · FY2025 · HL

Mechanistic Insights of Premature Ventricular Contractions-induced Cardiomyopathy

$675,918
Jose Francisco Huizar · Virginia Commonwealth University · R01 · FY2019 · HL

Preclinical Assays of Hippocampal-Prefrontal Cortical Circuit Engagement for Application in Therapeutic Development

$675,874
Andrew Porter Maurer · University Of Florida · R01 · FY2024 · MH

Inflammation and Cardiovascular Disease in Rheumatoid Arthritis

$675,863
Joan Marie Bathon · Columbia University Health Sciences · R01 · FY2022 · AR

Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships

$675,842
Sharon L Kardia · University Of Michigan At Ann Arbor · R01 · FY2015 · HL

Integration of structure and signaling in cardiac pacemaker function

$675,808
Vadim V Fedorov · Ohio State University · R01 · FY2019 · HL